top of page

PT Djembatan Dua Showcases Local Medical Consumables Innovations at Hisfarsi 2026 to Support Hospital Pharmacy Services

  • 3 days ago
  • 3 min read

PT Djembatan Dua reaffirmed its commitment to delivering professional healthcare solutions by introducing innovative locally manufactured Medical Consumables (Bahan Medis Habis Pakai/BMHP). This commitment was demonstrated through the launch of three new additions to its Stardec portfolio during the 2026 Annual Scientific Meeting (PIT) and National Working Meeting (Mukernas) of the Indonesian Hospital Pharmacists Association (Hisfarsi), held in Pekanbaru, Riau, from 25–27 June 2026.


Held under the theme "Building a Safer Healthcare System: The Pharmacist's Role in Digital and Performance Innovation," Hisfarsi 2026 brought together 1,185 hospital pharmacists from across Indonesia.


The event served as a collaborative platform for regulators, professional associations, academia, the pharmaceutical industry, and healthcare providers to strengthen the transformation of pharmacy services nationwide.



In line with efforts to improve healthcare efficiency, PT Djembatan Dua showcased locally manufactured medical consumables with a high Domestic Component Level (TKDN), import-quality standards, and competitive pricing. These innovations are expected to provide hospitals with reliable alternatives that enhance service quality while improving procurement efficiency.


During the event, PT Djembatan Dua introduced three new products Stardec I.V. Film, Stardec I.V. Film Kids, and Stardec DecaFoam further expanding the Stardec portfolio to meet the evolving needs of healthcare facilities.


Among the highlights was Stardec DecaFoam, an advanced foam dressing designed for the management of active wounds with moderate to heavy exudate, including diabetic ulcers and malignant wounds. Featuring a non-adherent wound contact layer, Stardec DecaFoam minimizes pain during dressing changes while reducing the risk of tissue damage, providing greater patient comfort and supporting the wound healing process.


PT Djembatan Dua also introduced Stardec I.V. Film and Stardec I.V. Film Kids, transparent fixation dressings developed to protect intravenous (IV) catheter insertion sites for both adult and pediatric patients. The products are designed to secure IV access while enabling continuous visual monitoring of the insertion site, enhancing patient comfort throughout treatment.


In addition to these latest innovations, PT Djembatan Dua also showcased DecaBio, its blood glucose monitoring solution, further strengthening the company's portfolio in supporting diabetes screening across healthcare facilities.


Mrs. Ni Luh Putu Yulina Enstini, National Business & Sales Manager of PT Djembatan Dua, stated that the expansion of the Stardec portfolio reflects the company's commitment to providing innovative medical consumables that address the evolving needs of hospitals and pharmacy practice.


"Through the continued development of the Stardec portfolio, we aim to deliver high-quality, locally manufactured medical consumables that are competitive and capable of supporting healthcare professionals in providing the best possible care for patients. Stardec DecaFoam represents one of our latest innovations in modern wound care, offering greater patient comfort while improving the effectiveness of clinical services in healthcare facilities," she said.



All Stardec products are manufactured by PT Deca Metric Medica (DMM), which has obtained Good Manufacturing Practice for Medical Devices (CPAKB) certification from the Indonesian Ministry of Health, ISO 13485:2016 certification, and Halal certification from Indonesia's Halal Product Assurance Agency (BPJPH).


Hisfarsi 2026 was attended by Mr. Taruna Ikrar, Head of the Indonesian Food and Drug Authority (BPOM); Mrs. Rizka Andalucia, Director General of Pharmaceuticals and Medical Devices at the Indonesian Ministry of Health; SF Hariyanto, Acting Governor of Riau; and Ruslan M. Rauf, Chairman of the Executive Board of Hisfarsi.


PT Djembatan Dua's participation in Hisfarsi 2026 reinforces the company's commitment to advancing professional healthcare solutions through innovative, locally manufactured medical consumables that are high-quality, globally competitive, and capable of supporting greater efficiency while improving the quality of hospital healthcare services across Indonesia.


 
 
bottom of page